A week in Japan tech
- NEC begins research on diagnosis and treatment of kidney disease using bioinfomatics. The firm will collaborate with biotechnology start-up JGS and Niigata University to develop new drugs to identify the genes and proteins that cause IgA nephropathy, and to monitor its onset and progression. IgA nephropathy is a type of Bright's disease, the most chronic form of glomerulonephritis.
- KDDI to launch an IP service aimed at business users....